While when AST-treated AD cell models were cotreated with 3-MA, Baf A1, and chloroquine (CQ), the ratios of p-PI3K/PI3K, p-Akt/Akt, and p-mTOR/mTOR were significantly increased (Fig. 8B–I). This evidence concerns the gene AKT1 and Alzheimer disease.